Arvind Utchanah
Director of Finance/CFO chez KNIGHT THERAPEUTICS INC.
Fortune : 153 413 $ au 31/03/2024
Postes actifs de Arvind Utchanah
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KNIGHT THERAPEUTICS INC. | Director of Finance/CFO | 30/03/2020 | - |
| Public Communications Contact | - | - | |
| Corporate Officer/Principal | 20/06/2016 | 30/03/2020 |
Historique de carrière de Arvind Utchanah
Anciens postes connus de Arvind Utchanah
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PALADIN LABS INC. | Comptroller/Controller/Auditor | 01/01/2012 | 01/06/2016 |
| Director of Finance/CFO | 01/01/2012 | 01/06/2016 |
Formation de Arvind Utchanah
| McGill University | Undergraduate Degree |
| Concordia University | Graduate Degree |
Statistiques
Internationale
| Canada | 5 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Public Communications Contact | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KNIGHT THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
- Bourse
- Insiders
- Arvind Utchanah
- Expérience
